Article Details
Retrieved on: 2024-11-16 15:31:31
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Intellia Therapeutics' CRISPR-based treatment for ATTR amyloidosis, focusing on protein folding and its role in disease progression. It reports on a study showing improved outcomes and safety in patients, related to tags like Transthyretin and Vutrisiran.
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here